ALS Phase 3 Study Dexpramipexole (KNS-760704) treatment evaluations

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Oct 10, 2012 (Started Sep 10, 2011)

Effectiveness

Can't tell (for Participate in clinical trial)
Effectiveness

Can't tell (for amyotrophic lateral sclerosis)
Side effects

None (for Overall)
Adherence

Always
Burden

Not at all hard to take

Dosage: 2 Daily

0 helpful marks

▲ Back to top